![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 04, 2010 12:37:10 AM
The Inolife website says that InoLife is in a strategic partnership with InoHealth. I have also heard it said here on Ihub that InoLife sells InoHealth products. In either case, whether InoLife is in a partnership or acting as an agent, I believe that there are many circumstances in which InoLife could be held equally or partially liable for a faulty product or misrepresentation of one or more products.
If InoHealth is sued by a doctor, a client, or the lab stock price -- and the stockholders -- would would suffer. If the Federal government pursued InoHealth and/or InoLife (and the officers of the two companies) for an act of wrong-doing, I believe that the damage to the price of the stock could not be undone.
The FDA-approved Paternity that is mentioned on the InoHealth page of the InoLife website is only one example of a very possible situation that could cause legal liability.
The InoHealth page on the InoLife web site says that InoHealth provides the IHP FDA-Approved Paternity Test. On the associated page on the InoHealth website, which appears to be under revision, it says, "Legally binding AABB-accredited DNA tests are available and include shipment of the testing supplies."
The Genetic Laboratories, Inc. provides this definition of AABB accreditation:
"To be an "accredited legal paternity test" the AABB requires that the DNA sample kit be shipped to the unrelated witness and/or professional collector, be witnessed by a neutral third party with no interest in the outcome of the test. Furthermore, photographic proof of identity is required to be submitted with the test to verify the identity of the persons submitting the samples.
By definition, home (or "self-collected") paternity tests are not accredited unless they meet the above requirements."
Furthermore, this company provides proof of accreditation, which InoHealth does not. Here is the link to the GTL faq page, which presents its many qualification stamps:
http://www.gtldna.com/faq.html
And here is the link to the GTL accreditation definition:
http://www.gtldna.com/accredited.html
InoHealth's claim of an "IHP FDA-Approved Paternity Test" on the InoLife website and the claim of "Legally binding AABB-accredited DNA tests" on the associated page on the InoHealth website would appear to be untrue because the AABB stamp is not displayed on any of INOL's associated web pages or websites. -- and adding the stamps to any of the web pages or websites without authorization would be a Federal offense.
I apologize for such a lengthy post; however, although it is a complex issue, I do believe that INOL's potential liability is a reasonable concern -- especially because Gary stated in a recent SEC filing that he was not certain how long the company would be able to maintain its insurance.
Apprenante
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM